Amgen Inc Drug Patent Portfolio

Amgen Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amgen Inc News

Lawsuit filed against cancer drug researcher regarding tools for targeting mutations | Americas

16 Apr, 2026

Amgen Inc. shares (US0311621009): Can its advancements in biotechnology lead to new opportunities?

15 Apr, 2026

Amgen Inc. shares (US0311621009): Can the momentum of its obesity medication maintain long-term growth?

14 Apr, 2026

Amgen Inc. shares (US0311621009): Can the momentum from its obesity medication lead to further gains?

14 Apr, 2026

See More